North Star Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Sell
40,700
-870
-2% -$22.8K 0.04% 201
2026
Q1
$1.17M Sell
41,570
-1,992
-5% -$53K 0.05% 184
2025
Q4
$1.08M Sell
43,562
-7,758
-15% -$196K 0.04% 185
2025
Q3
$1.31M Sell
51,320
-4,053
-7% -$100K 0.05% 168
2025
Q2
$1.34M Sell
55,373
-5,541
-9% -$129K 0.06% 163
2025
Q1
$1.54M Sell
60,914
-3,135
-5% -$82K 0.07% 151
2024
Q4
$1.7M Sell
64,049
-15,453
-19% -$419K 0.08% 144
2024
Q3
$2.3M Sell
79,502
-6,090
-7% -$178K 0.1% 127
2024
Q2
$2.39M Sell
85,592
-27,679
-24% -$762K 0.11% 124
2024
Q1
$3.14M Sell
113,271
-12,318
-10% -$342K 0.15% 111
2023
Q4
$3.62M Sell
125,589
-7,327
-6% -$221K 0.19% 106
2023
Q3
$4.41M Sell
132,916
-4,557
-3% -$161K 0.25% 90
2023
Q2
$5.04M Sell
137,473
-3,849
-3% -$150K 0.28% 89
2023
Q1
$5.77M Sell
141,322
-2,266
-2% -$97.9K 0.34% 80
2022
Q4
$7.36M Sell
143,588
-2,973
-2% -$143K 0.46% 75
2022
Q3
$6.41M Sell
146,561
-2,156
-1% -$105K 0.44% 74
2022
Q2
$7.8M Sell
148,717
-2,846
-2% -$145K 0.51% 66
2022
Q1
$7.85M Sell
151,563
-4,064
-3% -$211K 0.43% 71
2021
Q4
$9.19M Sell
155,627
-485
-0.3% -$24K 0.46% 68
2021
Q3
$6.71M Sell
156,112
-438
-0.3% -$19.4K 0.37% 77
2021
Q2
$6.13M Buy
156,550
+1,965
+1% +$76.4K 0.34% 79
2021
Q1
$5.6M Sell
154,585
-13,706
-8% -$487K 0.34% 82
2020
Q4
$6.2M Sell
168,291
-23,775
-12% -$872K 0.39% 79
2020
Q3
$6.69M Buy
192,066
+1,846
+1% +$64.7K 0.49% 64
2020
Q2
$5.9M Sell
190,220
-3,311
-2% -$112K 0.47% 69
2020
Q1
$5.99M Sell
193,531
-14,997
-7% -$511K 0.58% 58
2019
Q4
$7.75M Sell
208,528
-996
-0.5% -$35.5K 0.56% 63
2019
Q3
$7.14M Sell
209,524
-2,387
-1% -$86.8K 0.56% 64
2019
Q2
$8.71M Sell
211,911
-1,618
-0.8% -$64.2K 0.68% 52
2019
Q1
$8.6M Sell
213,529
-4,104
-2% -$164K 0.7% 52
2018
Q4
$9.01M Sell
217,633
-5,288
-2% -$220K 0.85% 46
2018
Q3
$9.32M Sell
222,921
-4,357
-2% -$168K 0.75% 51
2018
Q2
$7.82M Sell
227,278
-84
-0% -$2.87K 0.67% 55
2018
Q1
$7.66M Sell
227,362
-3,241
-1% -$111K 0.69% 54
2017
Q4
$7.92M Sell
230,603
-18,525
-7% -$632K 0.71% 55
2017
Q3
$8.44M Sell
249,128
-7,289
-3% -$234K 0.84% 45
2017
Q2
$8.17M Sell
256,417
-3,890
-1% -$123K 0.83% 45
2017
Q1
$8.45M Sell
260,307
-832
-0.3% -$26.2K 0.89% 39
2016
Q4
$8.05M Buy
261,139
+2,689
+1% +$82.1K 0.89% 41
2016
Q3
$8.31M Sell
258,450
-5,088
-2% -$170K 0.94% 39
2016
Q2
$8.8M Sell
263,538
-2,703
-1% -$86.3K 1.03% 35
2016
Q1
$7.49M Buy
266,241
+1,636
+0.6% +$46.7K 0.88% 41
2015
Q4
$8.1M Buy
264,605
+5,364
+2% +$169K 0.97% 35
2015
Q3
$7.72M Buy
259,241
+14,402
+6% +$462K 0.96% 35
2015
Q2
$7.79M Buy
244,839
+1,105
+0.5% +$36K 0.89% 41
2015
Q1
$8.04M Sell
243,734
-13,634
-5% -$433K 0.91% 37
2014
Q4
$7.61M Sell
257,368
-4,452
-2% -$128K 0.87% 45
2014
Q3
$7.34M Buy
261,820
+254
+0.1% +$7.13K 0.88% 38
2014
Q2
$7.37M Buy
261,566
+3,120
+1% +$88.9K 0.86% 44
2014
Q1
$7.88M Sell
258,446
-3,863
-1% -$115K 0.94% 34
2013
Q4
$7.62M Sell
262,309
-7,868
-3% -$229K 0.92% 36
2013
Q3
$7.36M Buy
270,177
+1,005
+0.4% +$27.3K 0.96% 29
2013
Q2
$7.15M Buy
+269,172
New +$7.44M 1% 31

Other funds holding PFE

North Star Asset Management's PFE Position: Q2 2026 in Review

North Star Asset Management reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $22.8K and leaving 40,700 shares worth $980K. The position accounts for 0.04% of the portfolio, ranked #201.

North Star Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.32M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • North Star Asset Management held 40,700 shares of Pfizer worth $980K as of Q2 2026.
  • North Star Asset Management sold 870 Pfizer shares in Q2 2026, an estimated $22.8K.
  • Pfizer made up 0.04% of North Star Asset Management's portfolio in Q2 2026, its #201 holding.
  • North Star Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • North Star Asset Management's Pfizer position peaked at $9.32M in Q3 2018.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.